SalubrisBio
Gaithersburg
About SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $102.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: salubrisbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/salubrisbio-21017 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.